Articles

Results 1 to 5 of 601
Most popular |Most recent


Learning the Steps of the BPCIA's Patent Dance : notice of commercial marketing is mandatory

USA - September 30 2016 The Federal Circuit’s second opinion interpreting the Biologics Act in Amgen v. Apotex is dense, but the outcome is simple. There are two takeaways...

Jamie Kitano, Peter Strand.

Bio-Rad agrees to pay $55 million to resolve SEC bribery charges

USA - November 13 2014 A California-based clinical diagnostic and life science research company has reportedly agreed to pay $55 million to resolve U.S. Securities and...

Madeleine M. McDonough, Chris A. Johnson, Debra S. Dunne, John Simpson.

CNS drug approvals take longer, are rejected more often

USA - November 13 2014 A new Tufts Center for the Study of Drug Development report reveals that drugs to treat central nervous system (CNS) disorders take longer to develop...

Madeleine M. McDonough, Chris A. Johnson, Debra S. Dunne, John Simpson.

Ranbaxy loses FDA approval for two generics

USA, India - November 13 2014 According to a statement that Ranbaxy Laboratories Ltd. provided to the Bombay Stock Exchange Website, the U.S. Food and Drug Administration (FDA)...

Madeleine M. McDonough, Chris A. Johnson, Debra S. Dunne, John Simpson.

College research program partners with diagnostics firm

USA - November 13 2014 The Baylor College of Medicine and diagnostics company Miraca Holdings have reportedly formed a joint ventureBaylor Miraca Genetics...

Madeleine M. McDonough, Chris A. Johnson, Debra S. Dunne, John Simpson.